[Evaluation of selected risk factors in patients operated for uterine body carcinoma].
OBJECTIVE
Uterus body carcinoma ranks among to the most common malignant neoplasms. It is of special interest what kind of factor influences on the survival span of treated patients.


METHODS
Evaluation of selected risk factors such as: age, obesity, clinical stage, type and histologic differentiation and proliferation depths on the 5-year survival span.


METHODS
/Due to our research we analyzed 280 endometrium samples of patients with the diagnosis of endometrial cancer, who*.../ Analysis was made on the group of 280 endometrium carcinoma patients, who were operated in the Department of Obstetrics and Women Diseases, University School of Medicine in Bydgoszcz in 1982-2000 period, 221 of the total number of patients (78.8%) were in the cancer stage I, while 33 (11.9%) in stage II, followed by 26 (9.3%) in stage III.


RESULTS
The highest percentage of 5-year survival time was observed in the group of patients under age of 50. In patients with the clinical stage I and proliferation depths under 1/2 of myometrum the percentage of 5-year survival time was 91%. Adenocarcinoma was the most common type of cancer and also with the best prognosis (81% of 5-year survival). Neither histologic differentiation G1 nor G2 have an influence on the survival time of operated patients.


CONCLUSIONS
1. The proliferation depths, histologic type of the endometrial carcinoma and clinical stage are the major prognostic factors for the uterus body carcinoma. 2. Endometrial carcinoma in the group of patients under age of 50 is connected with the higher percentage of five-year survival time.
Katedry i Kliniki Połoznictwa i Chorób Kobiecych AM w Bydgoszczy.
Marek
M
Grabiec
Marek
M
Szymański
Wiesław
W
Szymański
Jacek
J
Fórmaniak
D000230:Adenocarcinoma / Q000209:etiology* / Q000601:surgery*; D000328:Adult; D017677:Age Distribution; D000367:Age Factors; D000368:Aged; D002277:Carcinoma / Q000209:etiology / Q000601:surgery; D016889:Endometrial Neoplasms / Q000209:etiology* / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D009765:Obesity / Q000150:complications; D011237:Predictive Value of Tests; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D016019:Survival Analysis; D002583:Uterine Cervical Neoplasms / Q000209:etiology / Q000601:surgery